These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7791003)
1. Correlation between meta(tetrahydroxyphenyl)chlorin (m-THPC) biodistribution and photodynamic effects in mice. Morlet L; Vonarx-Coinsmann V; Lenz P; Foultier MT; de Brito LX; Stewart C; Patrice T J Photochem Photobiol B; 1995 Apr; 28(1):25-32. PubMed ID: 7791003 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo spectrofluorometry of a water-soluble meta-(tetrahydroxyphenyl)chlorin (m-THPC) derivative. Morlet L; Vonarx V; Foultier MT; Gouyette A; Stewart C; Lenz P; Patrice T J Photochem Photobiol B; 1997 Jul; 39(3):249-57. PubMed ID: 9253200 [TBL] [Abstract][Full Text] [Related]
3. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma. Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829 [TBL] [Abstract][Full Text] [Related]
4. PDT effects of m-THPC and ALA, phototoxicity and apoptosis. Bourré L; Rousset N; Thibaut S; Eléouet S; Lajat Y; Patrice T Apoptosis; 2002 Jun; 7(3):221-30. PubMed ID: 11997666 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics. Jones HJ; Vernon DI; Brown SB Br J Cancer; 2003 Jul; 89(2):398-404. PubMed ID: 12865935 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements. Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834 [TBL] [Abstract][Full Text] [Related]
7. Long circulating half-life and high tumor selectivity of the photosensitizer meta-tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma. Westerman P; Glanzmann T; Andrejevic S; Braichotte DR; Forrer M; Wagnieres GA; Monnier P; van den Bergh H; Mach JP; Folli S Int J Cancer; 1998 Jun; 76(6):842-50. PubMed ID: 9626351 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of Radachlorin(R) sensitizer for photodynamic therapy. Douillard S; Olivier D; Patrice T Photochem Photobiol Sci; 2009 Mar; 8(3):405-13. PubMed ID: 19255683 [TBL] [Abstract][Full Text] [Related]
9. Use of alkaline Comet assay to assess DNA repair after m-THPC-PDT. Rousset N; Keminon E; Eléouet S; Le Néel T; Auget JL; Vonarx V; Carré J; Lajat Y; Patrice T J Photochem Photobiol B; 2000 Jul; 56(2-3):118-31. PubMed ID: 11079472 [TBL] [Abstract][Full Text] [Related]
10. Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice. Coutier S; Bezdetnaya LN; Foster TH; Parache RM; Guillemin F Radiat Res; 2002 Sep; 158(3):339-45. PubMed ID: 12175311 [TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval. Andrejevic-Blant S; Hadjur C; Ballini JP; Wagnières G; Fontolliet C; van den Bergh H; Monnier P Br J Cancer; 1997; 76(8):1021-8. PubMed ID: 9376261 [TBL] [Abstract][Full Text] [Related]
13. Foscan uptake and tissue distribution in relation to photodynamic efficacy. Cramers P; Ruevekamp M; Oppelaar H; Dalesio O; Baas P; Stewart FA Br J Cancer; 2003 Jan; 88(2):283-90. PubMed ID: 12610515 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, and in vitro and in vivo evaluation of a diphenylchlorin sensitizer for photodynamic therapy. Bourré L; Simonneaux G; Ferrand Y; Thibaut S; Lajat Y; Patrice T J Photochem Photobiol B; 2003 Mar; 69(3):179-92. PubMed ID: 12695032 [TBL] [Abstract][Full Text] [Related]
15. Effects of meta-tetrahydroxyphenylchlorin photodynamic therapy on isogenic colorectal cancer SW480 and SW620 cells with different metastatic potentials. Abdulrehman G; Xv K; Li Y; Kang L Lasers Med Sci; 2018 Sep; 33(7):1581-1590. PubMed ID: 29796953 [TBL] [Abstract][Full Text] [Related]
16. The high photoactivity of m-THPC in photodynamic therapy. Unusually strong retention of m-THPC by RIF-1 cells in culture. Ball DJ; Vernon DI; Brown SB Photochem Photobiol; 1999 Mar; 69(3):360-3. PubMed ID: 10089829 [TBL] [Abstract][Full Text] [Related]
17. Monitoring interstitial m-THPC-PDT in vivo using fluorescence and reflectance spectroscopy. Kruijt B; van der Ploeg-van den Heuvel A; de Bruijn HS; Sterenborg HJ; Amelink A; Robinson DJ Lasers Surg Med; 2009 Nov; 41(9):653-64. PubMed ID: 19802884 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model. Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429 [TBL] [Abstract][Full Text] [Related]
19. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. Peng Q; Moan J; Ma LW; Nesland JM Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978 [TBL] [Abstract][Full Text] [Related]
20. Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model. Goff BA; Blake J; Bamberg MP; Hasan T Br J Cancer; 1996 Oct; 74(8):1194-8. PubMed ID: 8883404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]